1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69B9C754404BE2BBE65258344002FA87C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-communicating-medical-information-dissemination-protection-information-shared-with-external-stakeholders?opendocument
18
19opendocument
2052.201.27.211
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Communication

Best Practices in Communicating Medical Information: Dissemination & Protection of Information Shared with External Stakeholders

ID: 5530


Features:

9 Info Graphics

9 Data Graphics

120+ Metrics

7 Narratives

14 Best Practices


Pages/Slides: 26


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Best Practices in Communicating Medical Information: Dissemination & Protection of Information Shared with External Stakeholders”


STUDY OVERVIEW


Medical Information groups within pharmaceutical, biotechnology and medical device companies are responsible for disseminating vital and diverse information to key external stakeholders. However, sometimes it is important to exercise caution while sharing medical information assets with external stakeholders such as HCPs and payers.

Best Practices, LLC undertook this benchmarking research to probe how Medical Information groups within leading organizations communicate on and off-label information to key external stakeholders, and protect inadvertent use of information within slide decks and other medical information assets. This study also highlights the best practices in distributing slide decks.

Insights in this benchmarking study are presented in two segments: Large Companies Segment and Small-Mid Sized Companies Segment.


KEY TOPICS

  • Distribution of Medical Information
  • Protecting Medical Information
  • Best Practices in Distributing Slide Decks to External Stakeholders

KEY METRICS

  • Do you provide slide decks with off-label information to HCPs or others in order to communicate information through scientific exchange?
  • To which of the listed stakeholder groups do you provide medical information slide decks?
  • What methods of distribution do you use to disseminate information and slide decks from Medical Information?
  • What protections do you use for slide decks or other Medical Information assets?
  • Are your Medical Information slide decks locked or are left editable?

SAMPLE KEY FINDINGS

  • E-mail and Postal Remain Medical Information Mode of Distribution:
    • Medical Information slide decks are typically shared via e-mail or snail mail.
    • E-mail remains most prevalent means by which any medical information is shared. Ninety percent or more of companies use this method.
    • Small number of companies have begun to use chat and portals to disseminate data.

METHODOLOGY

Best Practices, LLC engaged 31 Medical Information professionals from 26 leading companies in this benchmarking research. Research analysis and recommendations are presented into two segments: Large Companies Segment (>$10B in revenue) and Small-Mid Sized Companies Segment (<$10B in revenue).


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Laboratories


Companies Profiled:
Abbott; AbbVie; Amicus Therapeutics; Bayer; Boehringer Ingelheim; BTG plc; CSL Behring; Depomed; Eisai; EMD Serono; Enlyton; Glenmark; GRAIL; Grifols; Jazz Pharmaceuticals; Juno Therapeutics; Medtronic; Merck; Merz Pharma; Novartis; Novo Nordisk; Pfizer; Pierre Fabre; Santen; Shire; Vifor Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.